Abstract
Serologic tests for equine influenza virus (EIV) antibodies are used for many purposes, including retrospective diagnosis, subty** of virus isolates, antigenic comparison of different virus strains, and measurement of immune responses to EIV vaccines. The hemagglutination inhibition (HI) assay, single radial hemolysis (SRH), and serum micro-neutralization tests are the most widely used for these purposes and are described here. The presence of inhibitors of hemagglutination in equine serum complicates interpretation of HI assay results, and there are alternative protocols (receptor-destroying enzyme, periodate, trypsin-periodate) for their removal. With the EIV H3N8 strains in particular, equine antibody titers may be magnified by pre-treating the HI test antigen with Tween-80 and ether. The SRH assay offers stronger correlations between serum antibody titers and protection from disease. Other tests are sometimes used for specialized purposes such as the neuraminidase-inhibition assay for subty**, or ELISA for measuring different specific antibody isotypes, and are not described here.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
OIE (2012) Manual of diagnostic tests and vaccines for terrestrial animals, vol 2, 7th edn. World Organisation for Animal Health (OIE), Paris, pp 865–878. 2.5.7
Hirst GK (1941) The agglutination of red cells by allantoic fluid of chick embryos infected with influenza virus. Science 94:22–23
Salk JE (1944) Simplified procedure for titrating hemagglutinating capacity of influenza virus and the corresponding antibody. J Immunol 49:87–98
Palmer DF, Coleman MT, Dowdle WR, Schild GC (1975) Advanced laboratory techniques for influenza diagnosis. US Department of Health and Human Services. Atlanta, GA
Ryan-Poirier KA, Kawaoka Y (1991) Distinct glycoprotein inhibitors of influenza A virus in different animal sera. J Virol 65:389–395
Pritchett TJ, Paulson JC (1989) Basis for the potent inhibition of influenza virus infection by equine and guinea pig alpha 2-macroglobulin. J Biol Chem 264:9850–9858
Boliar S, Stanislawek W, Chambers TM (2006) Inability of kaolin treatment to remove nonspecific inhibitors from equine serum for the hemagglutination inhibition test against equine H7N7 influenza virus. J Vet Diagn Investig 18:264–267
Subbarao EK, Kawaoka Y, Ryan-Poirier K, Clements ML, Murphy BR (1992) Comparison of different approaches to measuring influenza A virus-specific hemagglutination inhibition antibodies in the presence of serum inhibitors. J Clin Microbiol 30:996–999
John TJ, Fulginiti VA (1966) Parainfluenza 2 virus: increase in hemagglutinin titer on treatment with Tween-80 and ether. Proc Soc Exp Biol Med 121:109–111
Schild GC, Pereira MS, Chakraverty P (1975) Single-radial-hemolysis: a new method for the assay of antibody to influenza haemagglutinin. Applications for diagnosis and seroepidemiologic surveillance of influenza. Bull World Health Organ 52:43–50
Mumford J (2000) Collaborative study for the establishment of three European Pharmacopoeia Biological Reference Preparations for equine influenza horse antiserum. Pharmeuropa Bio 2000-1(Special Issue):5–21
Mumford JA, Wilson H, Hannant D, Jessett DM (1994) Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant. Epidemiol Infect 112:421–437
Yates P, Mumford JA (2000) Equine influenza vaccine efficacy: the significance of antigenic variation. Vet Microbiol 74:173–177
Newton JR, Daly JM, Spencer L, Mumford JA (2006) Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease. Vet Rec 158:185–192
Daly J, Daas A, Behr-Gross ME (2007) Collaborative study for the establishment of a candidate equine influenza subtype 2 American-like strain A/eq/South Africa/4/03 - horse antiserum biological reference preparation. Pharmaeuropa Bio 2007(1):7–14
Osterhaus A, Fouchier R, Rimmelzwaan G (2011) Towards universal influenza vaccines? Philos Trans R Soc Lond Ser B Biol Sci 366:2766–2773
Yamanaka T, Cullinane A, Gildea S, Bannai H, Nemoto M, Tsujimura K, Kondo T, Matsumura T (2015) The potential impact of a single amino-acid substitution on the efficacy of equine influenza vaccines. Equine Vet J 47:456-462
Harmon MW, Rota PA, Walls HH, Kendal AP (1988) Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection. J Clin Microbiol 26:333–337
Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. Am J Hyg 27:493–497
Morley PS, Bogdan JR, Townsend HG, Haines DM (1995) The effect of changing single radial hemolysis assay method when quantifying influenza A antibodies in serum. Vet Microbiol 44:101–110
Morley PS, Hanson LK, Bogdan JR, Townsend HG, Appleton JA, Haines DM (1995) The relationship between single radial hemolysis, hemagglutination inhibition, and virus neutralization assays used to detect antibodies specific for equine influenza viruses. Vet Microbiol 45:81–92
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.
About this protocol
Cite this protocol
Chambers, T.M., Reedy, S.E. (2020). Equine Influenza Serological Methods. In: Spackman, E. (eds) Animal Influenza Virus. Methods in Molecular Biology, vol 2123. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0346-8_31
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0346-8_31
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0345-1
Online ISBN: 978-1-0716-0346-8
eBook Packages: Springer Protocols